ABVC BioPharma, Inc.
ABVC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,259 | -$7,788 | -$16,312 | -$12,036 |
| Dep. & Amort. | $201 | $380 | $24 | $12 |
| Deferred Tax | $0 | $0 | $865 | $824 |
| Stock-Based Comp. | $0 | $186 | $7,037 | $5,307 |
| Change in WC | -$408 | $309 | $636 | -$1,614 |
| Other Non-Cash | $3,657 | $2,726 | $353 | -$91 |
| Operating Cash Flow | -$1,809 | -$4,187 | -$7,398 | -$7,598 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$21 | -$120 | -$18 |
| Net Acquisitions | $0 | $0 | -$1,602 | -$681 |
| Inv. Purchases | $0 | $0 | -$1,602 | -$108 |
| Inv. Sales/Matur. | $0 | $0 | $3,204 | $788 |
| Other Inv. Act. | $0 | -$339 | -$1,602 | -$788 |
| Investing Cash Flow | $0 | -$360 | -$1,722 | -$806 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $16 | $1,276 | $350 | -$591 |
| Stock Issued | $31 | $0 | $3,664 | $11,119 |
| Stock Repurch. | -$7 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,941 | $2,594 | $0 | -$533 |
| Financing Cash Flow | $1,981 | $3,870 | $4,014 | $9,996 |
| Forex Effect | -$25 | $2 | -$67 | -$28 |
| Net Chg. in Cash | $147 | -$675 | -$5,173 | $1,564 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $717 | $1,392 | $6,565 | $5,001 |
| End Cash | $864 | $717 | $1,392 | $6,565 |
| Free Cash Flow | -$1,809 | -$4,208 | -$7,518 | -$7,615 |